S-1

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

SEC Filing Details

Document Details

Form
Filing Date
Nov 25, 2020
Document Date
Nov 25, 2020
Form Description
Registration statement for face-amount certificate companies
Filing Group
Registration Statements
Company
KemPharm
Issuer
KEMPHARM, INC